Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 841

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 841
---
 for the purchase of up to 7,861,752 Shares, which were to be issued in three series; 3,930,876 Series A warrants; 1,965,438 Series B1 warrants; and 1,965,438 Series B2 warrants, under the conditions detailed below: The warrants terms Each warrant of Series A would be exercisable for one Share, starting from the date of issuance and until July 31, 2022, for an exercise price of NIS 3.5 (USD $1.08). Each warrant of Series B1 would be exercisable for one Share, starting from the date of issuance and until April 3, 2023, for an exercise price of NIS 4.4 (USD $1.35) Each warrant of Series B2 would be exercisable for one Share, starting from the occurrence of a vesting event until April 30, 2023, against a cash payment of an exercise price of NIS 4.4 (USD $1.35); A “vesting event” was defined as the Company’s completion of a public financing process in an amount not less than NIS 10,000,000 (USD $3,113,000) (net of interested party investments in the Company, as applicable) during the period that began after the completion of this issuance and ends on October 30, 2021 (see Note 18F). The warrants’ value, USD $2,389,000, was determined according to the Black -Scholesmodel based on the following assumptions:

| Expected share price volatility (%) |     | 74% – 75%    |
| Risk-free interest rate (%)         |     | 0.1%         |
| Share price (USD)                   |     | 1.129 – 1.05 |

As of July 9, 2021, the receipt of the total Consideration according to the investment agreements was completed, at USD $6,859 thousand, and after deducting the issuance expenses, USD $346,000, the Company received a total of USD $6,513,000. On April 30, 2023, 3,930,876 non -marketableequity -basedSeries B1 and B2 warrants expired. F.On October 21, 2021, the Company’s Board of Directors gave its approval, following approval of the audit committee, for a private investment in the Company in the aggregate amount